Vaccinations in patients with multiple sclerosis: a real-world, single-center experience
Vaccines prevent infections in patients with multiple sclerosis (MS). Though recommendations regarding vaccinating patients with MS have been recently published, real-world data regarding vaccines' planning in patients receiving disease-modifying drugs (DMDs) for MS are missing. Our aim was, th...
Saved in:
Main Authors: | Elvira Sbragia (Author), Dario Olobardi (Author), Giovanni Novi (Author), Caterina Lapucci (Author), Maria Cellerino (Author), Giacomo Boffa (Author), Alice Laroni (Author), Malgorzata Mikulska (Author), Laura Sticchi (Author), Matilde Inglese (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systemic sclerosis and vaccinations: a three-year register-based cohort study about vaccination rate and uptake from Liguria referral center, northwest Italy
by: Giuseppe Murdaca, et al.
Published: (2022) -
Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers
by: Matteo Bauckneht, et al.
Published: (2019) -
Nonwalking response to fampridine in patients with multiple sclerosis in a real-world setting
by: Francisco Alejandro Rodriguez-Leal, et al.
Published: (2019) -
The Age-Related Efficacy of Dimethyl Fumarate and Natalizumab in the Real-World Management of Multiple Sclerosis
by: Roberto De Masi, et al.
Published: (2021) -
Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave?
by: Laura Sticchi, et al.
Published: (2021)